Fasoracetam (Standard)
Fasoracetam (NS 105) Standard is the analytical standard of Fasoracetam (HY-107481). This product is intended for research and analytical applications. Fasoracetam (NS105) is an orally active metabotropic glutamate receptor (mGluR) activator. Fasoracetam bidirectionally regulates adenylyl cyclase activity and cAMP levels by activating group I-III mGluRs, upregulating GABAB receptors, and enhancing cholinergic neurotransmission. Fasoracetam can be used in research on attention deficit hyperactivity disorder (ADHD), depression, dementia, Alzheimer's disease, and forebrain ischemia.
For research use only. We do not sell to patients.
- Purity : 98%
- CAS No.: 110958-19-5
- Formula: C10H16N2O2
- Molecular Weight:196.25
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Purity & Documentation
-
Help & FAQs
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 110958-19-5
-
Molecular Weight 196.25
-
Formula C10H16N2O2
-
SMILES
O=C([C@@H]1NC(CC1)=O)N2CCCCC2
-
Synonyms
NS 105 (Standard)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Elia J, et al. Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling. Nature communications. 2018 Jan 16;9(1):4. [Content Brief]
[2]. Hirouchi M, et al. Role of metabotropic glutamate receptor subclasses in modulation of adenylyl cyclase activity by a nootropic NS-105. European journal of pharmacology. 2000 Jan 03;387(1):9-17. [Content Brief]
[4]. Ogasawara T, et al. Involvement of cholinergic and GABAergic systems in the reversal of memory disruption by NS-105, a cognition enhancer. Pharmacology, biochemistry, and behavior. 1999 Sep;64(1):41-52. [Content Brief]
[5]. Shorvon S. Pyrrolidone derivatives. The Lancet. 2001 Dec 1;358(9296):1885-92. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Fasoracetam (Standard) Related Classifications
HY-107481R Related Classifications
Powered by Bioz